Magnetic thermoradiotherapy for lung cancer: evaluation in A549−based preclinical models - Top-Institutions - MDSpire

Magnetic thermoradiotherapy for lung cancer: evaluation in A549−based preclinical models

By
Agnieszka Stawarska
Magdalena Bamburowicz-Klimkowska
Artur Kasprzak
Monika Ruzycka-Ayoush
Michal Bystrzejewski
Maria Wojewodzka
Michal Wieteska
Ireneusz P. Grudzinski
May 11, 2026
0 min

Frontiers In Oncology

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

The University of Texas MD Anderson Cancer Center

Houston, Texas
Key Differentiators
- Oncology
- Radiation Oncology
#2

Levine Cancer Institute, Atrium Health

Charlotte, North Carolina
Key Differentiators
- Oncology
#3

Chuiyangliu Hospital affiliated with Tsinghua University

Beijing, China
Key Differentiators
- Oncology
#4

Stanford University

Stanford, California
Key Differentiators
- Oncology
#5

Hokkaido University

Sapporo, Japan
Key Differentiators
- Oncology

Original Source(s)

Frontiers In Oncology

Magnetic thermoradiotherapy for lung cancer: evaluation in A549−based preclinical models

by Agnieszka Stawarska, Magdalena Bamburowicz-Klimkowska, Artur Kasprzak, Monika Ruzycka-Ayoush, Michal Bystrzejewski, Maria Wojewodzka, Michal Wieteska, Ireneusz P. Grudzinski
May 11, 2026

Related Content

Frontiers In Oncology

Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

May 28, 2026

Frontiers In Oncology

Emerging applications of artificial intelligence for risk stratification in head and neck cancer: a scoping review

Frontiers In Oncology

Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications